Search

Search Results
Results 4751 - 4757 of 4757 for multiple sclerosis
  • Drug - 6 Aug 2025
    Consumer Medicine Information (CMI) about Abrilada intended for persons living in Australia.
  • White Paper - 24 Jul 2025
    Explore how cytokines contribute to autoimmune disease development and discover emerging therapies.
  • White Paper - 28 Oct 2019
    Reviewing the ligands mostly used as experimental tools for cannabinoid receptors can give a wider understanding of endocannabinoid systems.
  • Supplier - 8 Dec 2025
    LifeArc® is a medical research charity making life science life changing, transforming promising life science ideas into medical breakthroughs that change patients’ lives.
  • Supplier - 14 Dec 2017
    Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
  • Supplier - 1 Jun 2023
    Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
  • Supplier - 23 Dec 2024
    Welcome to the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.